Connect with us
DAPA Banner
DAPA Coin
DAPA
COIN PAYMENT ASSET
PRIVACY · BLOCKDAG · HOMOMORPHIC ENCRYPTION · RUST
ElGamal Encrypted MINE DAPA
🚫 GENESIS SOLD OUT
DAPAPAY COMING

Business

Plug Power’s SWOT analysis: hydrogen stock faces profitability test

Published

on

Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Business

S&P 500 Snapshot: 8-Week Win Streak, Longest Since 2023

Published

on

S&P 500 Snapshot: Best Week In 4 Months

S&P Market Index Concept with Financial Graphs

AlexSecret/iStock via Getty Images

By Jennifer Nash

Despite a rough start to the week, the S&P 500 rallied in the back half to post its eighth consecutive weekly gain, its longest streak since 2023. Ultimately rising 0.9%, the index is now inches away

Advertisement
Continue Reading

Business

Lyell Immunopharma, Inc. (LYEL) Presents at Stifel 2026 Targeted Oncology Virtual Forum Transcript

Published

on

OneWater Marine Inc. (ONEW) Q1 2026 Earnings Call Transcript

Lyell Immunopharma, Inc. (LYEL) Stifel 2026 Targeted Oncology Virtual Forum May 20, 2026 4:00 PM EDT

Company Participants

Lynn Seely – Principal Executive Officer, President, CEO & Director

Advertisement

Conference Call Participants

Stephen Willey – Stifel, Nicolaus & Company, Incorporated, Research Division

Presentation

Advertisement

Stephen Willey
Stifel, Nicolaus & Company, Incorporated, Research Division

All right. Good afternoon, everyone. I’m Stephen Willey, one of the senior biotech analysts here at Stifel. I’m very glad to have with us in the next session, Lynn Seely, who is the President and CEO of Lyell. Lynn, thanks for joining us. Always appreciate it. Any opening statements you want to make or a brief overview of the company you want to provide before we jump into Q&A?

Lynn Seely
Principal Executive Officer, President, CEO & Director

Advertisement

Sure. I’m happy to give an overview for those who may not be as familiar with Lyell maybe for the record, I should say I’ll be making some forward-looking statements here. So consult our website. But for those of you who don’t know Lyell Immunopharma, we are a cell therapy company, and we’re focused on next-generation cell therapies, both for patients with hematologic malignancies as well as for solid tumors. And we have 2 lead programs in the clinic, both for large markets one in large B-cell lymphoma, where we intend to displace the currently approved CD19 CARs, which have a $3 billion and growing marketplace. And then the second, very novel CAR for metastatic colorectal cancer. So I look forward to telling you about those. / And then I should also just make note of the fact that Lyell is a little bit unique in that we have our own manufacturing like facility where we can launch from that facility and get well into launch with our own manufacturing. So that puts control under our own destiny, which we really like.

Advertisement
Continue Reading

Business

US arms sales to Taiwan unrelated to Iran war, source says

Published

on

US arms sales to Taiwan unrelated to Iran war, source says


US arms sales to Taiwan unrelated to Iran war, source says

Continue Reading

Business

Politics And The Markets 05/23/26

Published

on

OneWater Marine Inc. (ONEW) Q1 2026 Earnings Call Transcript

This is the forum for daily political discussion on Seeking Alpha. A new version is published every market day.

Please don’t leave political comments on other articles or posts on the site.

The comments below are not regulated with the same rigor as the rest of the site, and this is an ‘enter at your own risk’ area as discussion can get very heated. If you can’t stand the heat… you know what they say…

More on Today’s Markets:

Advertisement

Moderation Guidelines:

We remove comments under the following categories:

  • Personal attacks on another user account
  • Anti-Vaxxer or covid related misinformation
  • Stereotyping, prejudiced or racist language about individuals or the topic under discussion.
  • Inciting violence messages, encouraging hate groups and political violence.

Regardless of which side of the political divide you find yourself, please be courteous and don’t direct abuse at other users.

For any issue with regards to comments please email us at : moderation@seekingalpha.com.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Advertisement
Continue Reading

Business

Futu Holdings repurchases $160 million of ADSs under buyback plan

Published

on


Futu Holdings repurchases $160 million of ADSs under buyback plan

Continue Reading

Business

Autodesk’s SWOT analysis: stock navigates transformation with AI push

Published

on


Autodesk’s SWOT analysis: stock navigates transformation with AI push

Continue Reading

Business

Community Financial System Stock: Valuation Offsets Strong Asset Quality Growth (NYSE:CBU)

Published

on

Community Financial System Stock: Valuation Offsets Strong Asset Quality Growth (NYSE:CBU)

This article was written by

Daniel is an avid and active professional investor.
He runs Crude Value Insights, a value-oriented newsletter aimed at analyzing the cash flows and assessing the value of companies in the oil and gas space. His primary focus is on finding businesses that are trading at a significant discount to their intrinsic value by employing a combination of Benjamin Graham’s investment philosophy and a contrarian approach to the market and the securities therein. Learn more.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Advertisement
Continue Reading

Business

Venu Holding Stock: Cash Problems Still Evident Despite Large Capital Raises (NYSE:VENU)

Published

on

Venu Holding Stock: Cash Problems Still Evident Despite Large Capital Raises (NYSE:VENU)

This article was written by

Long-only investment, evaluating companies from an operational, buy-and-hold perspective.Quipus Capital does not focus on market-driven dynamics and future price action. Instead, our articles focus on operational aspects, understanding the long-term earnings power of companies, the competitive dynamics of the industries where they participate, and buying companies that we would like to hold independently of how the price moves in the future. Most QC calls will be holds, and that is by design. Only a very small fraction of companies should be a buy at any point in time. However, hold articles provide important information for future investors and a healthy dose of skepticism to a relatively bullish-biased market.Disclaimer: All of the author’s articles are written on an “as is” basis and without warranty. They represent the author’s opinion only and in no way constitute professional investment advice. It is the responsibility of the reader to conduct their due diligence and seek investment advice from a licensed professional before making any investment decisions. The author disclaims all liability for any actions taken based on the information contained in any articles published.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Advertisement
Continue Reading

Business

Jury clears Boeing of fraud in $153 million 737 Max lawsuit by LOT Polish Airlines

Published

on


Jury clears Boeing of fraud in $153 million 737 Max lawsuit by LOT Polish Airlines

Continue Reading

Business

Upgrading eGain Stock As Market Ignores Compelling Growth Catalysts (NASDAQ:EGAN)

Published

on

Upgrading eGain Stock As Market Ignores Compelling Growth Catalysts (NASDAQ:EGAN)

This article was written by

Dr. Duru has blogged about financial markets since the year 2000. A veteran of the dot-com bubble and bust, the financial crisis, and the coronavirus pandemic, he fully appreciates the value in trading and investing around the extremes of market behavior. In this spirit, his blog “One-Twenty Two” delivers a different narrative for students and fans of financial markets. Dr. Duru challenges conventional market wisdoms and offers unique perspectives. The blog posts cover stocks, options, currencies, Bitcoin, and more, while leveraging the tools of both technical and fundamental analysis for short-term and long-term trading and investing. Some of these ideas and analyses are also featured here on Seeking Alpha.Dr. Duru received a B.S. in Mechanical Engineering (and an honors degree in Values, Technology, Science and Society – now simply STS) from Stanford University. For graduate studies, Dr. Duru went on to earn a Ph.D. in Engineering-Economic Systems (now Management, Science, and Society). Dr. Duru’s work experiences include:*Independent consulting in operations research and decision analysis*Management consulting in product development and technology strategy*Price optimization software for computer manufacturers and internet advertising (including a shared patent for methodology)*Business Intelligence and Data Analytics, including some Data Science and Data Engineering

Analyst’s Disclosure: I/we have a beneficial long position in the shares of EGAN either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Advertisement
Continue Reading

Trending

Copyright © 2025